Skip to main content
. 2020 Jul 3;10:954. doi: 10.3389/fonc.2020.00954

Figure 5.

Figure 5

Forest plot of risk ratios (RRs) comparing adverse events (AEs) of any grade or grade 3 or higher in patients treated with PARP inhibitors vs. placebo or chemotherapy.